FMO5
Aliases:
This biomarker is also known as:- dimethylaniline oxidase 5
- flavin containing monooxygenase 5
- FMO 5
- FMO5
- Dimethylaniline oxidase 5
- Hepatic flavin-containing monooxygenase 5
- EC 1.14.13.8
- hepatic flavin-containing monooxygenase 5
- dimethylaniline monooxygenase [N-oxide-forming] 5
Description…
From NCBI Gene: Metabolic N-oxidation of the diet-derived amino-trimethylamine (TMA) is mediated by flavin-containing monooxygenase and is subject to an inherited FMO3 polymorphism in man resulting in a small subpopulation with reduced TMA N-oxidation capacity resulting in fish odor syndrome Trimethylaminuria. Three forms of the enzyme, FMO1 found in fetal liver, FMO2 found in adult liver, and FMO3 are encoded by genes clustered in the 1q23-q25 region. Flavin-containing monooxygenases are NADPH-dependent flavoenzymes that catalyzes the oxidation of soft nucleophilic heteroatom centers in drugs, pesticides, and xenobiotics. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2009]
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| Type: | Gene |
| HGNC Name: | FMO5 |
The following organs have data associated with this biomarker…
Attributes
| Phase: | 1 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
- History and molecular genetics of Lynch syndrome in family G: a century later.
- Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.
- Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis.